Similar articles for PMID: 22920081

Year	Number of Results
1957	1
1961	1
1999	1
2000	1
2001	2
2002	3
2003	7
2004	4
2005	3
2006	5
2007	5
2008	4
2009	7
2010	5
2011	23
2012	34
2013	15
2014	20
2015	9
2016	9
2017	6
2018	8
2019	10
2020	5
2021	1
2022	1
2024	0

1

Omalizumab treatment in a child with severe asthma and multiple steroid-induced morbidities.

Rizk C, Ring A, Santucci S, MacLusky I, Karsh J, Yang WH. Rizk C, et al. Ann Allergy Asthma Immunol. 2012 Sep;109(3):222-3. doi: 10.1016/j.anai.2012.06.021. Epub 2012 Jul 15. Ann Allergy Asthma Immunol. 2012. PMID: 22920081 No abstract available.

2

[Omalizumab treatment in patients with asthma: summary of Meir Medical Center experience with 47 patients].

Shitrit D, Talker O, Metabichek A, Yaakovi I. Shitrit D, et al. Harefuah. 2012 Apr;151(4):216-9, 254, 253. Harefuah. 2012. PMID: 22616149 Hebrew.

3

Omalizumab in the treatment of asthma.

Tan R, Corren J. Tan R, et al. Expert Rev Respir Med. 2011 Dec;5(6):747-56. doi: 10.1586/ers.11.73. Expert Rev Respir Med. 2011. PMID: 22082161 Review.

4

Summaries for patients. Omalizumab therapy for patients with severe asthma.

[No authors listed] [No authors listed] Ann Intern Med. 2011 May 3;154(9):I28. doi: 10.7326/0003-4819-154-9-201105030-00001. Ann Intern Med. 2011. PMID: 21536934 Free article. No abstract available.

5

Oral corticosteroid sparing with omalizumab in severe allergic (IgE-mediated) asthma patients.

Siergiejko Z, Świebocka E, Smith N, Peckitt C, Leo J, Peachey G, Maykut R. Siergiejko Z, et al. Curr Med Res Opin. 2011 Nov;27(11):2223-8. doi: 10.1185/03007995.2011.620950. Epub 2011 Sep 21. Curr Med Res Opin. 2011. PMID: 21933100 Clinical Trial.

6

Use of omalizumab to improve desensitization safety in allergen immunotherapy.

Larenas-Linnemann D, Wahn U, Kopp M. Larenas-Linnemann D, et al. J Allergy Clin Immunol. 2014 Mar;133(3):937-937.e2. doi: 10.1016/j.jaci.2013.12.1089. J Allergy Clin Immunol. 2014. PMID: 24581432 No abstract available.

7

The use of biological agents for the treatment of fungal asthma and allergic bronchopulmonary aspergillosis.

Moss RB. Moss RB. Ann N Y Acad Sci. 2012 Dec;1272:49-57. doi: 10.1111/j.1749-6632.2012.06810.x. Ann N Y Acad Sci. 2012. PMID: 23231714

8

Effect of omalizumab as add-on therapy on asthma-related quality of life in severe allergic asthma: a Brazilian study (QUALITX).

Rubin AS, Souza-Machado A, Andradre-Lima M, Ferreira F, Honda A, Matozo TM; QUALITX Study Investigators. Rubin AS, et al. J Asthma. 2012 Apr;49(3):288-93. doi: 10.3109/02770903.2012.660297. Epub 2012 Feb 23. J Asthma. 2012. PMID: 22356355 Clinical Trial.

9

Impact of omalizumab on emergency-department visits, hospitalizations, and corticosteroid use among patients with uncontrolled asthma.

Lafeuille MH, Dean J, Zhang J, Duh MS, Gorsh B, Lefebvre P. Lafeuille MH, et al. Ann Allergy Asthma Immunol. 2012 Jul;109(1):59-64. doi: 10.1016/j.anai.2012.04.015. Epub 2012 May 12. Ann Allergy Asthma Immunol. 2012. PMID: 22727159

10

Omalizumab therapy in severe asthma: experience from the Spanish registry--some new approaches.

Vennera Mdel C, Pérez De Llano L, Bardagí S, Ausin P, Sanjuas C, González H, Gullón JA, Martínez-Moragón E, Carretero JA, Vera E, Medina JF, Alvarez FJ, Entrenas LM, Padilla A, Irigaray R, Picado C; Spanish Registry. Vennera Mdel C, et al. J Asthma. 2012 May;49(4):416-22. doi: 10.3109/02770903.2012.668255. Epub 2012 Mar 23. J Asthma. 2012. PMID: 22443408

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

177 results

Results by year